Found 3 hits Enz. Inhib. hit(s) with Target = 'Glucagon receptor' and Ligand = 'BDBM50007215' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Glucagon receptor
(Homo sapiens (Human)) | BDBM50007215
(CHEMBL3237927)Show SMILES CC(C)C[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cc(Cl)cc(Cl)c1)c1ccc(cc1)C(=O)NCc1nn[nH]n1 |r,wU:13.17,4.3,wD:10.11,c:8,(6.83,-40.7,;8.15,-39.91,;9.5,-40.66,;8.13,-38.37,;9.46,-37.59,;9.4,-36.05,;10.62,-35.1,;12.09,-35.51,;10.08,-33.65,;8.54,-33.71,;8.12,-35.19,;6.94,-34.2,;5.49,-34.74,;5.23,-36.25,;6.41,-37.24,;7.86,-36.71,;3.79,-36.79,;2.6,-35.8,;2.34,-37.32,;3.53,-38.3,;10.86,-32.32,;10.1,-30.99,;10.87,-29.66,;10.11,-28.32,;12.42,-29.66,;13.18,-31,;14.72,-31.01,;12.4,-32.33,;10.78,-38.37,;10.76,-39.92,;12.09,-40.7,;13.43,-39.95,;13.45,-38.41,;12.13,-37.62,;14.76,-40.74,;14.74,-42.28,;16.1,-39.99,;17.42,-40.77,;18.76,-40.02,;20.16,-40.65,;21.2,-39.52,;20.45,-38.18,;18.94,-38.48,)| Show InChI InChI=1S/C32H39Cl2N7O2/c1-19(2)14-26(20-6-8-21(9-7-20)29(42)35-18-27-37-39-40-38-27)41-30(43)28(22-15-24(33)17-25(34)16-22)36-32(41)12-10-23(11-13-32)31(3,4)5/h6-9,15-17,19,23,26H,10-14,18H2,1-5H3,(H,35,42)(H,37,38,39,40)/t23-,26-,32-/m1/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet 
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [125I]-glucagon from recombinant human GCGR expressed in CHO cells after 60 mins by scintillation counting analysis |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Mus musculus) | BDBM50007215
(CHEMBL3237927)Show SMILES CC(C)C[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cc(Cl)cc(Cl)c1)c1ccc(cc1)C(=O)NCc1nn[nH]n1 |r,wU:13.17,4.3,wD:10.11,c:8,(6.83,-40.7,;8.15,-39.91,;9.5,-40.66,;8.13,-38.37,;9.46,-37.59,;9.4,-36.05,;10.62,-35.1,;12.09,-35.51,;10.08,-33.65,;8.54,-33.71,;8.12,-35.19,;6.94,-34.2,;5.49,-34.74,;5.23,-36.25,;6.41,-37.24,;7.86,-36.71,;3.79,-36.79,;2.6,-35.8,;2.34,-37.32,;3.53,-38.3,;10.86,-32.32,;10.1,-30.99,;10.87,-29.66,;10.11,-28.32,;12.42,-29.66,;13.18,-31,;14.72,-31.01,;12.4,-32.33,;10.78,-38.37,;10.76,-39.92,;12.09,-40.7,;13.43,-39.95,;13.45,-38.41,;12.13,-37.62,;14.76,-40.74,;14.74,-42.28,;16.1,-39.99,;17.42,-40.77,;18.76,-40.02,;20.16,-40.65,;21.2,-39.52,;20.45,-38.18,;18.94,-38.48,)| Show InChI InChI=1S/C32H39Cl2N7O2/c1-19(2)14-26(20-6-8-21(9-7-20)29(42)35-18-27-37-39-40-38-27)41-30(43)28(22-15-24(33)17-25(34)16-22)36-32(41)12-10-23(11-13-32)31(3,4)5/h6-9,15-17,19,23,26H,10-14,18H2,1-5H3,(H,35,42)(H,37,38,39,40)/t23-,26-,32-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 420 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [125I]-glucagon from GCGR in mouse liver membranes after 60 mins by scintillation counting analysis |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Glucagon receptor
(Homo sapiens (Human)) | BDBM50007215
(CHEMBL3237927)Show SMILES CC(C)C[C@@H](N1C(=O)C(=N[C@@]11CC[C@@H](CC1)C(C)(C)C)c1cc(Cl)cc(Cl)c1)c1ccc(cc1)C(=O)NCc1nn[nH]n1 |r,wU:13.17,4.3,wD:10.11,c:8,(6.83,-40.7,;8.15,-39.91,;9.5,-40.66,;8.13,-38.37,;9.46,-37.59,;9.4,-36.05,;10.62,-35.1,;12.09,-35.51,;10.08,-33.65,;8.54,-33.71,;8.12,-35.19,;6.94,-34.2,;5.49,-34.74,;5.23,-36.25,;6.41,-37.24,;7.86,-36.71,;3.79,-36.79,;2.6,-35.8,;2.34,-37.32,;3.53,-38.3,;10.86,-32.32,;10.1,-30.99,;10.87,-29.66,;10.11,-28.32,;12.42,-29.66,;13.18,-31,;14.72,-31.01,;12.4,-32.33,;10.78,-38.37,;10.76,-39.92,;12.09,-40.7,;13.43,-39.95,;13.45,-38.41,;12.13,-37.62,;14.76,-40.74,;14.74,-42.28,;16.1,-39.99,;17.42,-40.77,;18.76,-40.02,;20.16,-40.65,;21.2,-39.52,;20.45,-38.18,;18.94,-38.48,)| Show InChI InChI=1S/C32H39Cl2N7O2/c1-19(2)14-26(20-6-8-21(9-7-20)29(42)35-18-27-37-39-40-38-27)41-30(43)28(22-15-24(33)17-25(34)16-22)36-32(41)12-10-23(11-13-32)31(3,4)5/h6-9,15-17,19,23,26H,10-14,18H2,1-5H3,(H,35,42)(H,37,38,39,40)/t23-,26-,32-/m1/s1 | PDB
MMDB
UniProtKB/SwissProt
B.MOAD
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| n/a | n/a | 760 | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Antagonist activity at human GCGR expressed in CHO cells assessed as inhibition of glucagon-stimulated cAMP production preincubated for 30 mins follo... |
J Med Chem 57: 2601-10 (2014)
Article DOI: 10.1021/jm401858f
BindingDB Entry DOI: 10.7270/Q20V8F9P |
More data for this
Ligand-Target Pair | |
Search and Browse
